Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccines.
Kallen KJ, Heidenreich R, Schnee M, Petsch B, Schlake T, Thess A, Baumhof P, Scheel B, Koch SD, Fotin-Mleczek M. Kallen KJ, et al. Among authors: schlake t. Hum Vaccin Immunother. 2013 Oct;9(10):2263-76. doi: 10.4161/hv.25181. Epub 2013 Jun 4. Hum Vaccin Immunother. 2013. PMID: 23921513 Free PMC article. Review.
Developing mRNA-vaccine technologies.
Schlake T, Thess A, Fotin-Mleczek M, Kallen KJ. Schlake T, et al. RNA Biol. 2012 Nov;9(11):1319-30. doi: 10.4161/rna.22269. Epub 2012 Oct 12. RNA Biol. 2012. PMID: 23064118 Free PMC article. Review.
mRNA mediates passive vaccination against infectious agents, toxins, and tumors.
Thran M, Mukherjee J, Pönisch M, Fiedler K, Thess A, Mui BL, Hope MJ, Tam YK, Horscroft N, Heidenreich R, Fotin-Mleczek M, Shoemaker CB, Schlake T. Thran M, et al. Among authors: schlake t. EMBO Mol Med. 2017 Oct;9(10):1434-1447. doi: 10.15252/emmm.201707678. EMBO Mol Med. 2017. PMID: 28794134 Free PMC article.
mRNA: A Novel Avenue to Antibody Therapy?
Schlake T, Thran M, Fiedler K, Heidenreich R, Petsch B, Fotin-Mleczek M. Schlake T, et al. Mol Ther. 2019 Apr 10;27(4):773-784. doi: 10.1016/j.ymthe.2019.03.002. Epub 2019 Mar 6. Mol Ther. 2019. PMID: 30885573 Free PMC article. Review.
mRNA as novel technology for passive immunotherapy.
Schlake T, Thess A, Thran M, Jordan I. Schlake T, et al. Cell Mol Life Sci. 2019 Jan;76(2):301-328. doi: 10.1007/s00018-018-2935-4. Epub 2018 Oct 17. Cell Mol Life Sci. 2019. PMID: 30334070 Free PMC article. Review.
mRNA as a Novel Treatment Strategy for Hereditary Spastic Paraplegia Type 5.
Hauser S, Poenisch M, Schelling Y, Höflinger P, Schuster S, Teegler A, Betten R, Gustafsson JÅ, Hübener-Schmid J, Schlake T, Chevessier-Tünnesen F, Horscroft N, Björkhem I, Schöls L. Hauser S, et al. Among authors: schlake t. Mol Ther Methods Clin Dev. 2019 Oct 31;15:359-370. doi: 10.1016/j.omtm.2019.10.011. eCollection 2019 Dec 13. Mol Ther Methods Clin Dev. 2019. PMID: 31828178 Free PMC article.
38 results